Instil Historical Balance Sheet

TIL Stock

USD 23.01 0.84 3.52%

Trend analysis of Instil Bio balance sheet accounts such as Net Tangible Assets of 670.4 M, Property Plant And Equipment Net of 116.1 M, Net Debt of 92.8 M or Accounts Payable of 2.2 M provides information on Instil Bio's total assets, liabilities, and equity, which is the actual value of Instil Bio to its prevalent stockholders. By breaking down trends over time using Instil Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Instil Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Instil Bio is a good buy for the upcoming year.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.

About Instil Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Instil Bio at a specified time, usually calculated after every quarter, six months, or one year. Instil Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Instil Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Instil currently owns. An asset can also be divided into two categories, current and non-current.

Instil Bio Balance Sheet Chart

At this time, Instil Bio's Cash And Short Term Investments are quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 384.2 M this year, although the value of Total Stockholder Equity will most likely fall to about 241.6 M.

Total Assets Other Current Liab Total Current Liabilities Property Plant And Equipment Net

Add Fundamental

Total Assets

Total assets refers to the total amount of Instil Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Instil Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Instil Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Instil Bio are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from Instil Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Instil Bio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.At this time, Instil Bio's Cash And Short Term Investments are quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 384.2 M this year, although the value of Total Stockholder Equity will most likely fall to about 241.6 M.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	28.0M	7.6M	8.7M	8.3M
Total Assets	482.1M	325.6M	374.5M	384.2M

Other Current Liab Total Assets

Instil Bio balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Net Working Capital	Property Plant Equipment	Other Liab	Non Currrent Assets Other	Other Assets	Net Receivables
Total Assets		0.9	0.95	0.91	0.86	0.91	0.09	-0.76	0.79	0.32	0.93	0.97	0.45	0.43	0.92	0.79	0.54	0.91	0.9	0.98	0.97	0.93	0.42	0.49	0.56	0.87
Other Current Liab	0.9		0.97	0.91	0.69	0.77	0.0	-0.5	0.85	0.24	0.77	0.92	0.14	0.21	0.84	0.64	0.34	0.88	0.76	0.92	0.91	0.72	0.11	0.78	0.73	0.74
Total Current Liabilities	0.95	0.97		0.93	0.77	0.81	0.06	-0.59	0.86	0.25	0.81	0.96	0.26	0.27	0.87	0.72	0.39	0.9	0.8	0.96	0.95	0.81	0.24	0.68	0.68	0.76
Total Stockholder Equity	0.91	0.91	0.93		0.89	0.85	0.36	-0.72	0.69	-0.06	0.86	0.87	0.4	0.02	0.97	0.87	0.15	0.99	0.84	0.88	0.87	0.86	0.37	0.62	0.69	0.9
Net Tangible Assets	0.86	0.69	0.77	0.89		0.92	0.57	-0.94	0.43	-0.12	0.93	0.75	0.68	0.12	0.9	0.99	0.21	0.93	0.92	0.76	0.76	0.97	0.65	0.2	0.34	0.96
Property Plant And Equipment Net	0.91	0.77	0.81	0.85	0.92		0.36	-0.91	0.48	0.13	1.0	0.79	0.56	0.34	0.83	0.88	0.44	0.91	1.0	0.8	0.8	0.95	0.52	0.22	0.26	0.95
Net Debt	0.09	0.0	0.06	0.36	0.57	0.36		-0.58	-0.38	-0.84	0.33	-0.06	0.51	-0.6	0.32	0.68	-0.57	0.42	0.37	-0.05	-0.06	0.36	0.49	-0.23	-0.12	0.49
Retained Earnings	-0.76	-0.5	-0.59	-0.72	-0.94	-0.91	-0.58		-0.22	0.07	-0.92	-0.61	-0.69	-0.24	-0.75	-0.93	-0.31	-0.8	-0.92	-0.62	-0.62	-0.93	-0.66	0.08	-0.07	-0.91
Accounts Payable	0.79	0.85	0.86	0.69	0.43	0.48	-0.38	-0.22		0.52	0.5	0.91	0.0	0.4	0.7	0.34	0.51	0.62	0.46	0.9	0.9	0.54	0.0	0.8	0.83	0.44
Cash	0.32	0.24	0.25	-0.06	-0.12	0.13	-0.84	0.07	0.52		0.16	0.4	-0.13	0.93	0.0	-0.26	0.92	-0.07	0.13	0.4	0.41	0.14	-0.13	0.1	0.05	-0.06
Non Current Assets Total	0.93	0.77	0.81	0.86	0.93	1.0	0.33	-0.92	0.5	0.16		0.81	0.58	0.37	0.86	0.89	0.46	0.91	1.0	0.82	0.82	0.97	0.54	0.22	0.29	0.96
Cash And Short Term Investments	0.97	0.92	0.96	0.87	0.75	0.79	-0.06	-0.61	0.91	0.4	0.81		0.33	0.44	0.88	0.67	0.55	0.85	0.78	1.0	1.0	0.84	0.31	0.62	0.68	0.75
Common Stock Shares Outstanding	0.45	0.14	0.26	0.4	0.68	0.56	0.51	-0.69	0.0	-0.13	0.58	0.33		0.15	0.49	0.68	0.16	0.47	0.56	0.34	0.35	0.67	1.0	-0.29	-0.07	0.62
Non Current Liabilities Total	0.43	0.21	0.27	0.02	0.12	0.34	-0.6	-0.24	0.4	0.93	0.37	0.44	0.15		0.11	-0.01	0.99	0.05	0.34	0.44	0.45	0.37	0.14	-0.14	-0.13	0.14
Other Current Assets	0.92	0.84	0.87	0.97	0.9	0.83	0.32	-0.75	0.7	0.0	0.86	0.88	0.49	0.11		0.87	0.22	0.96	0.83	0.89	0.89	0.89	0.46	0.55	0.7	0.92
Other Stockholder Equity	0.79	0.64	0.72	0.87	0.99	0.88	0.68	-0.93	0.34	-0.26	0.89	0.67	0.68	-0.01	0.87		0.08	0.92	0.89	0.69	0.68	0.92	0.65	0.18	0.32	0.94
Total Liab	0.54	0.34	0.39	0.15	0.21	0.44	-0.57	-0.31	0.51	0.92	0.46	0.55	0.16	0.99	0.22	0.08		0.17	0.43	0.55	0.57	0.45	0.15	-0.03	-0.02	0.23
Net Invested Capital	0.91	0.88	0.9	0.99	0.93	0.91	0.42	-0.8	0.62	-0.07	0.91	0.85	0.47	0.05	0.96	0.92	0.17		0.9	0.86	0.85	0.9	0.44	0.52	0.59	0.95
Property Plant And Equipment Gross	0.9	0.76	0.8	0.84	0.92	1.0	0.37	-0.92	0.46	0.13	1.0	0.78	0.56	0.34	0.83	0.89	0.43	0.9		0.79	0.78	0.95	0.52	0.21	0.24	0.95
Total Current Assets	0.98	0.92	0.96	0.88	0.76	0.8	-0.05	-0.62	0.9	0.4	0.82	1.0	0.34	0.44	0.89	0.69	0.55	0.86	0.79		1.0	0.85	0.32	0.61	0.68	0.76
Net Working Capital	0.97	0.91	0.95	0.87	0.76	0.8	-0.06	-0.62	0.9	0.41	0.82	1.0	0.35	0.45	0.89	0.68	0.57	0.85	0.78	1.0		0.85	0.33	0.6	0.68	0.76
Property Plant Equipment	0.93	0.72	0.81	0.86	0.97	0.95	0.36	-0.93	0.54	0.14	0.97	0.84	0.67	0.37	0.89	0.92	0.45	0.9	0.95	0.85	0.85		0.64	0.2	0.33	0.93
Other Liab	0.42	0.11	0.24	0.37	0.65	0.52	0.49	-0.66	0.0	-0.13	0.54	0.31	1.0	0.14	0.46	0.65	0.15	0.44	0.52	0.32	0.33	0.64		-0.29	-0.07	0.58
Non Currrent Assets Other	0.49	0.78	0.68	0.62	0.2	0.22	-0.23	0.08	0.8	0.1	0.22	0.62	-0.29	-0.14	0.55	0.18	-0.03	0.52	0.21	0.61	0.6	0.2	-0.29		0.93	0.28
Other Assets	0.56	0.73	0.68	0.69	0.34	0.26	-0.12	-0.07	0.83	0.05	0.29	0.68	-0.07	-0.13	0.7	0.32	-0.02	0.59	0.24	0.68	0.68	0.33	-0.07	0.93		0.39
Net Receivables	0.87	0.74	0.76	0.9	0.96	0.95	0.49	-0.91	0.44	-0.06	0.96	0.75	0.62	0.14	0.92	0.94	0.23	0.95	0.95	0.76	0.76	0.93	0.58	0.28	0.39

Click cells to compare fundamentals

Instil Bio Account Relationship Matchups

Instil Bio balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	319.0M	610.0M	482.1M	325.6M	374.5M	384.2M
Other Current Liab	9.2M	35.3M	28.0M	7.6M	8.7M	8.3M
Total Current Liabilities	13.3M	41.4M	32.8M	10.6M	12.1M	21.9M
Total Stockholder Equity	(39.6M)	555.2M	363.6M	225.8M	259.7M	241.6M
Property Plant And Equipment Net	55.3M	122.0M	209.3M	141.1M	162.2M	116.1M
Net Debt	(241.7M)	(37.6M)	36.2M	76.9M	88.4M	92.8M
Retained Earnings	(44.9M)	(201.7M)	(424.9M)	(581.0M)	(522.9M)	(496.7M)
Accounts Payable	3.5M	5.6M	2.4M	1.2M	1.1M	2.2M
Cash	241.7M	37.6M	43.7M	9.2M	8.3M	7.9M
Non Current Assets Total	72.9M	146.0M	212.8M	164.9M	189.6M	131.3M
Cash And Short Term Investments	241.7M	454.1M	260.9M	150.4M	172.9M	245.5M
Liabilities And Stockholders Equity	319.0M	610.0M	482.1M	325.6M	374.5M	384.2M
Non Current Liabilities Total	345.3M	13.4M	85.7M	89.2M	80.3M	87.8M
Other Current Assets	1.3M	19.8M	8.5M	10.4M	12.0M	8.8M
Other Stockholder Equity	(326.4M)	757.0M	789.0M	807.2M	928.2M	974.6M
Total Liab	358.6M	54.8M	118.5M	99.8M	89.8M	103.7M
Net Invested Capital	(39.6M)	555.2M	436.0M	307.3M	353.3M	275.4M
Property Plant And Equipment Gross	55.3M	122.0M	217.8M	148.6M	170.9M	119.7M
Total Current Assets	246.1M	464.0M	269.4M	160.8M	184.9M	252.9M
Accumulated Other Comprehensive Income	(283K)	(87K)	(493K)	(348K)	(313.2K)	(328.9K)
Net Working Capital	232.9M	422.7M	236.6M	150.2M	172.7M	231.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Instil Bio is a strong investment it is important to analyze Instil Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instil Bio's future performance. For an informed investment choice regarding Instil Stock, refer to the following important reports:

How To Invest In Instil

Details

Is Instil Stock a good investment?

Details

What is Instil Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(11.56)

Return On Assets

(0.12)

Return On Equity

(0.37)

The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Instil Historical Balance Sheet

About Instil Balance Sheet Analysis

Instil Bio Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Instil Bio balance sheet Correlations

Instil Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Instil Bio balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Non Current Assets Total
Total Current Assets	+ 1.0	Cash And Short Term Investments
Net Working Capital	+ 1.0	Cash And Short Term Investments
Other Liab	+ 1.0	Common Stock Shares Outstanding

Retained Earnings	- 0.94	Net Tangible Assets
Property Plant Equipment	- 0.93	Retained Earnings
Other Stockholder Equity	- 0.93	Retained Earnings
Property Plant And Equipment Gross	- 0.92	Retained Earnings
Non Current Assets Total	- 0.92	Retained Earnings
Net Receivables	- 0.91	Retained Earnings